Medo Specia Pharma Private Limited
About Medo Specia Pharma Private Limited
Data last updated:
Medo Specia Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2000.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2000PTC129264. Its GSTIN is 27AACCM6480B1ZM (Maharashtra).
The company had an authorised share capital of ₹15 Lakh and a paid-up capital of ₹9.3 Lakh. It was led by directors Krishna Prasad Balasubramanian and Ashwin Prasad.
Its last annual general meeting (AGM) was held on 07 June 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at A – 101 Ghatkopar Industrial Estate L.B.S. Marg Ghatkopar (West), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.92 Cr, a decline of 50% compared to the previous year. For the same year it recorded a net profit of ₹7.16 Lakh (net margin 3.7%) and EBITDA of ₹6.82 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 286% over three years and 97% over five years.
The company had about 41 employees on its provident fund (EPFO) records before it was dissolved.
Court records list 1 case involving the company, including 1 filed against it.
Company details
Contact details
Medo Specia Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA – 101 Ghatkopar Industrial Estate L.B.S. Marg Ghatkopar (West), Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medo Specia Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medo Specia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medo Specia Pharma Private Limited, buy the company report.
Financials of Medo Specia Pharma Private Limited
FY 2021 filings availableMedo Specia Pharma Private Limited reported revenue of ₹1.92 Cr (down 50% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 50% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 97%. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.92 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medo Specia Pharma Private Limited, buy the company report.
Board of directors of Medo Specia Pharma Private Limited
Medo Specia Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Prasad Balasubramanian | Director | 03 Aug 2009 | 17 Years 2 Months | As last reported |
| Ashwin Prasad | Director | 27 Jul 2016 | 10 Years 3 Months | As last reported |
Peer comparison
Medo Specia Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adlac Life Science Private Limited | ₹1.94 Cr (FY 2025) | -21.0% | Kalol, Gujarat, India | |||
| MP Laboratories Private Limited | ₹1.93 Cr (FY 2024) | 26.0% | Chennai, Tamil Nadu, India | |||
| Medo Specia Pharma Private Limitedthis company | ₹1.92 Cr (FY 2021) | ₹7.16 Lakh | 3.7% | -50.0% | Mumbai, Maharashtra, India | |
| Phenomenon Nutritech Private Limited | ₹1.91 Cr (FY 2025) | 399.0% | Ahmedabad, Gujarat, India | |||
| Rege Engredea Private Limited | ₹1.91 Cr (FY 2018) | Nalgonda, Telangana, India |
To see the full peer comparison of Medo Specia Pharma Private Limited, buy the company report.
Auditor
Medo Specia Pharma Private Limited is audited by K A R M & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K A R M & CO | FY 2021 | 105237W |
Shareholding
The shareholding of Medo Specia Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medo Specia Pharma Private Limited, buy the company report.
Legal cases
Medo Specia Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Disposed |
To see the full case history of Medo Specia Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medo Specia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medo Specia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCM6480B1ZM | Maharashtra | Active | 03 Apr 2018 |
To see the full GST registrations and return filing status of Medo Specia Pharma Private Limited, buy the company report.
Recent activity
Medo Specia Pharma Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Ashwin Prasad ceased to be Additional Director on 29 Sep 2016.
Frequently asked questions
Medo Specia Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Medo Specia Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2000 and is registered under CIN U24239MH2000PTC129264. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Medo Specia Pharma was incorporated on 19 October 2000. It is registered with the Registrar of Companies, Mumbai.
Medo Specia Pharma had 2 directors:
- Krishna Prasad Balasubramanian - Director
- Ashwin Prasad - Director
The CIN (Corporate Identification Number) of Medo Specia Pharma is U24239MH2000PTC129264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Medo Specia Pharma is at A – 101 Ghatkopar Industrial Estate L.B.S. Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086.
The latest financial statements of Medo Specia Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 07 June 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Medo Specia Pharma is 27AACCM6480B1ZM, registered in Maharashtra.
Medo Specia Pharma operated in the pharma industry, in the drug formulation and development segment.
The peers of Medo Specia Pharma by revenue are Adlac Life Science Private Limited, MP Laboratories Private Limited, Phenomenon Nutritech Private Limited, Rege Engredea Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Medo Specia Pharma has 1 court case on record: 1 filed against it.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
